Top Stories
Features
Focus on Transplantation
Abstract Roundup
Columns
From the Chair
From the Field
News Briefs
Conferences
American Transplant Congress 2020
International Congress of the Transplantation Society
Kidney Week (ASN)
Spring Clinical Meetings (NKF)
American Nephrology Nurses Association (ANNA)
Diseases and Conditions
Acute Kidney Injury
ADPKD
Anemia
Chronic Kidney Disease
Diabetes and Hypertension
End-Stage Renal Disease
Hyperkalemia
Metabolic Acidosis
DocWire News
Search
Docwire News
Top Stories
Features
Focus on Transplantation
Abstract Roundup
Columns
From the Chair
From the Field
News Briefs
Conferences
American Transplant Congress 2020
International Congress of the Transplantation Society
Kidney Week (ASN)
Spring Clinical Meetings (NKF)
American Nephrology Nurses Association (ANNA)
Diseases and Conditions
Acute Kidney Injury
ADPKD
Anemia
Chronic Kidney Disease
Diabetes and Hypertension
End-Stage Renal Disease
Hyperkalemia
Metabolic Acidosis
DocWire News
Home
Diseases and Conditions
ADPKD
ADPKD
Tolvaptan for Treatment of ADPKD in Japan
March 19, 2021
Characteristics of Patients with ADPKD Treated with Tolvaptan in the United States
March 18, 2021
ADPKD Patients Experience Broad and Variable Trial Outcomes
January 28, 2021
Real-World Evidence of Tolvaptan Treatment for Patients with ADPKD
January 11, 2021
Outcomes of Transplantation with Kidneys from Deceased Donor with ADPKD
November 23, 2020
Simultaneous BNN and Kidney Transplantation in Patients with ADPKD
September 18, 2020
Kidney Transplantation in Patients with ADPKD
September 16, 2020
Outcomes of Transplantation with Kidney from Deceased Donor with ADPKD
September 16, 2020
Tolvaptan in Patients with ADPKD: Patient-Reported Outcomes
May 14, 2020
Tolvaptan for ADPKD: Two-Years of Follow-up
May 12, 2020
Load more
Subscribe to RSS
Subscribe to RSS